Get the Stockscreener App
2.21
2.65%
-0.05
After Hours:
2.19
-0.02
-0.90%
Redhill Biopharma Ltd Adr Stock (RDHL) Forecast
The Redhill Biopharma Ltd Adr (RDHL) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $44.45, representing a +1,911% increase from the current price of $2.21. The highest analyst price target is $75.52, and the lowest is $13.37.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month RDHL Price Target
Average 123.72
(+5,498% Upside)
Is Redhill Biopharma Ltd Adr (RDHL) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 38.42 | Neutral |
| STOCH(9,6) | 30.05 | Neutral |
| STOCHRSI(14) | 68.60 | Neutral |
| MACD(12,26) | -0.3064 | Buy |
| ADX(14) | 28.69 | Sell |
| William %R | -70.25 | Neutral |
| CCI(14) | -42.52 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.3204
Sell
|
2.2999
Sell
|
| MA20 |
2.4547
Sell
|
2.4871
Sell
|
| MA50 |
3.3199
Sell
|
3.339
Sell
|
| MA100 |
4.9977
Sell
|
4.7033
Sell
|
| MA200 |
7.0648
Sell
|
7.3161
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, RDHL could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 11 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on RDHL, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 38.42 indicates that RDHL is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 30.05 indicates that RDHL is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 68.6 indicates that RDHL is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 28.69 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -42.52 indicates that RDHL is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term RDHL price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Redhill Biopharma Ltd Adr financial reports and earnings history, Redhill Biopharma Ltd Adr (RDHL) stock could reach $314.53 by 2030, $203.19 by 2040 and $605.09 by 2050. See the projected annual prices until 2050 of the Redhill Biopharma Ltd Adr stock below:
- Redhill Biopharma Ltd Adr (RDHL) is expected to reach an average price of $59.77 in 2035, with a high prediction of $68.03 and a low estimate of $59.77. This indicates an $2,604% rise from the last recorded price of $2.21.
- Redhill Biopharma Ltd Adr (RDHL) stock is projected to chart a bullish course in 2040, with an average price target of $195.49, representing an $8,745% surge from its current level. The forecast ranges from a conservative $195.74 to a sky-high $203.19.
- Our analysts predict Redhill Biopharma Ltd Adr (RDHL) to jump 17,163% by 2045, soaring from $383.95 to an average price of $381.50, potentially reaching $383.73. While $383.95 is the low estimate, the potential upside is significant.
- Redhill Biopharma Ltd Adr (RDHL) stock is expected to climb by 2050, reaching an average of $575.80, a $25,954% jump from its current level. However, a wide range of estimates exists, with high and low targets of $605.09 and $609.25, respectively, highlighting the market's uncertainty.
Redhill Biopharma Ltd Adr Stock (RDHL) Year by Year Forecast
Redhill Biopharma Ltd Adr Stock (RDHL) Price Forecast for 2025
Redhill Biopharma Ltd Adr Stock (RDHL) is expected to reach an average price of $113.84 in 2025, with a high prediction of $226.34 and a low estimate of $1.3453. This indicates an +5,051% rise from the last recorded price of $2.21.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2025 | $33.37 | $13.37 | $75.52 | +1,410% |
| June, 2025 | $20.00 | $1.3453 | $112.83 | +805.07% |
| July, 2025 | $26.09 | $13.32 | $63.43 | +1,080% |
| August, 2025 | $30.71 | $15.14 | $72.20 | +1,290% |
| September, 2025 | $114.94 | $4.1701 | $128.54 | +5,101% |
| October, 2025 | $67.82 | $56.62 | $172.80 | +2,969% |
| November, 2025 | $183.25 | $71.48 | $226.34 | +8,192% |
| December, 2025 | $114.14 | $101.54 | $212.28 | +5,065% |
Redhill Biopharma Ltd Adr Stock (RDHL) Price Forecast for 2026
The predicted value for Redhill Biopharma Ltd Adr (RDHL) in 2026 is set at an average of $138.45. Estimates vary from a peak of $276.61 to a trough of $0.2891, indicating an +6,165% surge from the present price of $2.21.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $137.96 | $91.45 | $162.51 | +6,143% |
| February, 2026 | $130.19 | $109.93 | $152.99 | +5,791% |
| March, 2026 | $89.62 | $66.42 | $188.85 | +3,955% |
| April, 2026 | $234.10 | $93.47 | $246.10 | +10,493% |
| May, 2026 | $102.73 | $77.01 | $259.56 | +4,548% |
| June, 2026 | $98.56 | $70.16 | $115.77 | +4,360% |
| July, 2026 | $60.24 | $47.84 | $102.41 | +2,626% |
| August, 2026 | $108.47 | $55.70 | $121.67 | +4,808% |
| September, 2026 | $81.75 | $68.95 | $111.12 | +3,599% |
| October, 2026 | $110.38 | $58.01 | $113.46 | +4,894% |
| November, 2026 | $233.41 | $88.09 | $276.61 | +10,461% |
| December, 2026 | $17.89 | $0.2891 | $255.13 | +709.46% |
Redhill Biopharma Ltd Adr Stock (RDHL) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Redhill Biopharma Ltd Adr (RDHL) is $53.73, with a high forecast of $98.92 and a low forecast of $8.5459. This indicates an +2,331% increase from the last price of $2.21.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $71.72 | $8.5459 | $98.92 | +3,145% |
| February, 2027 | $43.66 | $34.09 | $83.97 | +1,875% |
| March, 2027 | $45.57 | $46.74 | $36.17 | +1,962% |
| April, 2027 | $48.55 | $52.12 | $42.95 | +2,097% |
| May, 2027 | $41.92 | $46.32 | $44.43 | +1,797% |
| June, 2027 | $68.63 | $50.06 | $49.43 | +3,006% |
| July, 2027 | $32.81 | $33.21 | $57.98 | +1,384% |
| August, 2027 | $48.18 | $32.95 | $42.18 | +2,080% |
| September, 2027 | $81.30 | $62.72 | $81.30 | +3,579% |
| October, 2027 | $94.43 | $80.24 | $84.67 | +4,173% |
| November, 2027 | $76.44 | $82.63 | $81.90 | +3,359% |
| December, 2027 | $67.96 | $73.16 | $76.87 | +2,975% |
Redhill Biopharma Ltd Adr Stock (RDHL) Price Forecast for 2028
In 2028, Redhill Biopharma Ltd Adr (RDHL) is projected to reach an average price of $67.11, with a high projection of $79.97 and a low estimate of $54.24. This indicates an +2,936% rise from the last price of $2.21.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $71.47 | $70.38 | $70.79 | +3,134% |
| February, 2028 | $81.80 | $71.87 | $76.50 | +3,601% |
| March, 2028 | $68.78 | $70.58 | $76.56 | +3,012% |
| April, 2028 | $76.96 | $70.74 | $72.79 | +3,382% |
| May, 2028 | $80.77 | $78.13 | $79.97 | +3,555% |
| June, 2028 | $75.98 | $76.28 | $79.70 | +3,338% |
| July, 2028 | $70.25 | $70.65 | $71.58 | +3,079% |
| August, 2028 | $65.45 | $65.73 | $68.40 | +2,862% |
| September, 2028 | $65.88 | $65.92 | $65.35 | +2,881% |
| October, 2028 | $62.77 | $62.87 | $64.60 | +2,740% |
| November, 2028 | $57.50 | $57.54 | $61.31 | +2,502% |
| December, 2028 | $54.20 | $54.24 | $56.39 | +2,353% |
Redhill Biopharma Ltd Adr Stock (RDHL) Price Forecast for 2029
The 2029 price forecast for Redhill Biopharma Ltd Adr Stock (RDHL) is $145.68 on average, with a high prediction of $290.30 and a low estimate of $1.0701. This represents an +6,492% increase from the previous price of $2.21.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $48.84 | $48.88 | $53.06 | +2,110% |
| February, 2029 | $44.98 | $45.01 | $47.73 | +1,935% |
| March, 2029 | $40.82 | $40.88 | $43.92 | +1,747% |
| April, 2029 | $37.12 | $37.18 | $39.59 | +1,580% |
| May, 2029 | $31.85 | $31.85 | $35.60 | +1,341% |
| June, 2029 | $26.27 | $26.35 | $30.72 | +1,089% |
| July, 2029 | $22.24 | $22.33 | $24.87 | +906.33% |
| August, 2029 | $17.84 | $17.86 | $21.10 | +707.06% |
| September, 2029 | $13.65 | $13.68 | $16.76 | +517.71% |
| October, 2029 | $8.4229 | $8.4341 | $12.48 | +281.13% |
| November, 2029 | $4.2255 | $4.3775 | $7.298 | +91.20% |
| December, 2029 | $310.70 | $1.0701 | $290.30 | +13,959% |
Redhill Biopharma Ltd Adr Stock (RDHL) Price Forecast for 2030
Redhill Biopharma Ltd Adr Stock (RDHL) is expected to reach an average price of $307.69 in 2030, with a high forecast of $334.45 and a low forecast of $280.94. This signifies an +13,823% surge from the last price of $2.21.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $323.73 | $322.47 | $314.53 | +14,548% |
| February, 2030 | $307.28 | $337.62 | $330.30 | +13,804% |
| March, 2030 | $322.82 | $297.16 | $316.93 | +14,507% |
| April, 2030 | $283.17 | $308.37 | $312.19 | +12,713% |
| May, 2030 | $294.20 | $280.94 | $283.20 | +13,212% |
| June, 2030 | $315.34 | $301.29 | $291.57 | +14,169% |
| July, 2030 | $320.38 | $289.92 | $301.98 | +14,397% |
| August, 2030 | $315.12 | $304.24 | $296.33 | +14,159% |
| September, 2030 | $296.27 | $305.07 | $296.29 | +13,306% |
| October, 2030 | $329.30 | $301.75 | $326.10 | +14,800% |
| November, 2030 | $346.85 | $359.36 | $334.45 | +15,594% |
| December, 2030 | $321.99 | $335.99 | $329.82 | +14,470% |
0.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):